Heterocyclic modulators of lipid synthesis
US-2024400552-A1 · Dec 5, 2024 · US
US2016016905A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016016905-A1 |
| Application number | US-201514748050-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 23, 2015 |
| Priority date | Jun 24, 2014 |
| Publication date | Jan 21, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a stilbazolium derivative represented by the general formula (I): wherein R 1 , R 2 , R 3 , and R 4 independently represent hydrogen, halogen, alkyl, hydroxyl, carboxyl, or amino; R 5 represents hydrogen or alkyl; X represents oxygen or NR 6 (R 6 is hydrogen or alkyl); and Y − represents an anion. In the general formula (I), some or all of hydrogens maybe deuterium.
Opening claim text (preview).
What is claimed is: 1 . A stilbazolium derivative represented by the following general formula (I): wherein R 1 , R 2 , R 3 , and R 4 independently represent hydrogen, halogen, alkyl, hydroxyl, carboxyl, or amino; R 5 represents hydrogen or alkyl; X represents oxygen or NR 6 (R 6 is hydrogen or alkyl); Y − represents an anion; and in the general formula (I), some or all of hydrogens maybe deuterium. 2 . A stilbazolium derivative represented by the following general formula (II): wherein R 1 and R 2 independently represent hydrogen or alkyl; X represents oxygen or NR 6 (R 6 is hydrogen or alkyl); Y − represents an anion; and in the general formula (II), some or all of hydrogens maybe deuterium. 3 . The stilbazolium derivative according to claim 1 , wherein Y − is a sulfonic acid anion. 4 . The stilbazolium derivative according to claim 2 , wherein Y − is a sulfonic acid anion. 5 . A stilbazolium derivative represented in the following formula (III). 6 . A nonlinear optical material comprising the stilbazolium derivative according to claim 1 . 7 . A nonlinear optical material comprising the stilbazolium derivative according to claim 2 . 8 . A nonlinear optical material comprising the stilbazolium derivative according to claim 5 . 9 . A light source device comprising the nonlinear optical material according to claim 6 as a light wavelength conversion element. 10 . A light source device comprising the nonlinear optical material according to claim 7 as a light wavelength conversion element. 11 . A light source device comprising the nonlinear optical material according to claim 8 as a light wavelength conversion element. 12 . A terahertz generation device comprising the nonlinear optical material according to claim 6 . 13 . A terahertz generation device comprising the nonlinear optical material according to claim 7 . 14 . A terahertz generation device comprising the nonlinear optical material according to claim 8 .
Crystals · CPC title
for second-harmonic generation {(G02F1/3532 takes precedence)} · CPC title
involving THZ radiation · CPC title
Naphthalene sulfonic acids · CPC title
Three-wave interaction, e.g. sum-difference frequency generation (G02F1/3532 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.